Chao Wu

机构：Beijing Tongren Hospital, Nanjing University of Chinese Medicine, Memorial Sloan Kettering Cancer Center, University of California, San Francisco, Capital Medical University, Tianjin Medical University General Hospital, Kettering University, STCube (United States), Nanjing Drum Tower Hospital, Hangzhou Hospital of Traditional Chinese Medicine, Hangzhou City University, Nanjing University · ORCID：0000-0003-0260-2868

发表论文 181 篇 · 总被引 4575 次 · h-index 35

代表论文

• Curcumin promotes ferroptosis in hepatocellular carcinoma via upregulation of ACSL4 (2024 · Journal of Cancer Research and Clinical Oncology · 被引 34)
• Cardiovascular-kidney-metabolic (CKM) syndrome is associated with increased mortality in individuals with metabolic dysfunction-associated steatotic liver disease (MASLD) (2025 · Communications Medicine · 被引 14)
• Transcription factor MEF2D regulates aberrant expression of ACSL3 and enhances sorafenib resistance by inhibiting ferroptosis in HCC (2024 · Frontiers in Pharmacology · 被引 12)
• Tailoring microbial fitness through computational steering and CRISPRi-driven robustness regulation (2024 · Cell Systems · 被引 8)
• Mediator kinase inhibition impedes transcriptional plasticity and prevents resistance to ERK/MAPK-targeted therapy in KRAS-mutant cancers (2024 · npj Precision Oncology · 被引 7)
• Enhancing chemotherapy response prediction via matched colorectal tumor-organoid gene expression analysis and network-based biomarker selection (2025 · Translational Oncology · 被引 6)